N4-hydroxycytidine (EIDD-1931) is a novel nucleoside analog with known anti-viral activity against SARS-CoV, SARS-CoV-2, respiratory syncytial virus (RSV), influenza A & B viruses (IAV & IBV), HCV, pestivirus, bovine viral diarrhoea virus (BVDV), Ebola virus (EBOV), Chikungunya virus (CHIKV), venezuelan equine encephalitis virus (VEEV).
N4-hydroxycytidine (EIDD-1931) is the active molecule in the antiviral pro-drug clinical candidate EIDD-2801 (Molnupiravir)
Cancer Research and Antivirals
|Appearance||White to off-white powder|
|MDL Number||Request if not shown|
Send us your enquiry for N4-Hydroxycytidine (EIDD-1931). We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for N4-Hydroxycytidine (EIDD-1931) email us and we will include your contribution on the website.